Glucagon like Peptide 1 News and Research

RSS

Produce prescription programs could save US healthcare system $40 billion

An apple a day not only keeps the doctor away, it also could save the United States at least $40 billion in medical bills, report Friedman School of Nutrition Science and Policy at Tufts University researchers in a new study published July 7 in the Journal of the American Heart Association.

7 Jul 2023

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Exercise plays a crucial role in managing type 2 diabetes, offering potential benefits such as improved glycemic control. This study explores exercise recommendations and their impact on dietary, medication, and behavioral factors for optimal diabetes care.

5 Jul 2023

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year's annual meeting of the American Diabetes Association (ADA) held June 23–26.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Diabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage.

26 Jun 2023

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.

21 Jun 2023

Carb conundrum: debunking the link between pasta and obesity

Researchers reviewed existing data on the impact of diet patterns with high pasta content on body weight.

13 Jun 2023

Diabetes drug reduces alcohol drinking by more than half in rats

The medication semaglutide, which is currently used in the treatment of type 2 diabetes and obesity, might also be an effective medication for alcohol dependence.

7 Jun 2023

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Orally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.

7 Jun 2023

How does tirzepatide stimulate insulin secretion?

Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.

6 Jun 2023

Do glucose-lowering medications have different effects on kidney outcomes?

Researchers evaluated the kidney outcomes in individuals with type 2 diabetes.

26 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Revolutionizing Schizophrenia Research with the Queensland Brain Institute

To commemorate World Schizophrenia Awareness Day, we spoke to three researchers from the Queensland Brain Institiute about their research, and why it is so important to raise awareness around Schizophrenia

23 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

Tirzepatide improves body composition across a range of adult age groups, study shows

A new analysis of SURMOUNT-1, the first Phase 3 study of tirzepatide in adults for chronic weight management shows that tirzepatide improves body composition across a range of adult age groups.

19 May 2023

What is the association between obesity and insulin resistance in youth and its production of colon-derived acetate, gut-derived hormone secretion, and adipose tissue lipolysis?

Researchers assessed whether insulin resistance and adiposity in youth were linked to the fermentation of dietary fibers.

11 May 2023

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Researchers explore the efficacy of current approaches to reduce the risk of cardiovascular events in patients with type 2 diabetes.

10 May 2023

Boosting gut health with short-chain fatty acids

Research paper provides an overview of short-chain fatty acids (SCFAs) and their role in regulating gut homeostasis. It also discusses SCFA-producing bacteria and potential therapeutic approaches to boost SCFA levels in the gut to treat related diseases.

9 May 2023

Glucagon like Peptide 1 News and Research

Produce prescription programs could save US healthcare system $40 billion

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Carb conundrum: debunking the link between pasta and obesity

Diabetes drug reduces alcohol drinking by more than half in rats

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

How does tirzepatide stimulate insulin secretion?

Do glucose-lowering medications have different effects on kidney outcomes?

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Revolutionizing Schizophrenia Research with the Queensland Brain Institute

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

Tirzepatide improves body composition across a range of adult age groups, study shows

What is the association between obesity and insulin resistance in youth and its production of colon-derived acetate, gut-derived hormone secretion, and adipose tissue lipolysis?

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Boosting gut health with short-chain fatty acids

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News